Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

IBRXIBRX
Showing 8 of 22 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in IMMUNITYBIO INC

NORTHERN TRUST CORP holds 3.6M shares of IBRX (IMMUNITYBIO INC), worth $31.2M as of 2026-Q2. The position was increased (+42.3% shares). IBRX represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$31.2M

Current Shares

3.6M

Total Value Change

+$26.7M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.6M
+42.3%
$31.2M0.0%$8.76
39
2026-Q1
Increased
2.5M
+12.3%
$19.2M0.0%$10.00
32
2025-Q4
Increased
2.2M
+11.3%
$4.4M0.0%$1.98
30
2025-Q3
Increased
2M
+8.7%
$4.9M0.0%$2.57
29
2025-Q2
Increased
1.8M
+35.8%
$4.9M0.0%$2.70
35
2025-Q1
Increased
1.4M
+2.6%
$4.1M0.0%$3.14
27
2024-Q4
Increased
1.3M
+7.9%
$3.4M0.0%$2.68
29
2024-Q3
Increased
1.2M
+7.4%
$4.6M0.0%$3.93
29

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used